IDYA vs REGN: Which Stock is Better?
Side-by-side comparison of Ideaya Biosciences Inc and Regeneron Pharmaceuticals Inc in 2026
IDYA
Ideaya Biosciences Inc
$33.91
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | IDYA | REGN | Winner |
|---|---|---|---|
| Market Cap | $2.85B | $78.87B | REGN |
| P/E Ratio | N/A | 17.98 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | 0.6% | 0.0% | IDYA |
| Gross Margin | -43.9% | 44.6% | REGN |
Analyze IDYA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IDYA or REGN a better investment?
Comparing IDYA and REGN: Ideaya Biosciences Inc has a market cap of $2.85B while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IDYA and REGN?
IDYA (Ideaya Biosciences Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IDYA or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IDYA or REGN?
IDYA has higher revenue growth at 0.6% vs 0.0% for REGN.
Which company is more profitable: IDYA or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -43.9% for IDYA.
Which is the larger company: IDYA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $2.85B for IDYA.
Should I buy IDYA or REGN in 2026?
Both IDYA and REGN have investment merit. IDYA trades at $33.91 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IDYA and REGN stock?
Key differences: Market Cap ($2.85B vs $78.87B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.6% vs 0.0%), Gross Margin (-43.9% vs 44.6%).